Growth Metrics

CapsoVision (CV) Payables (2024 - 2025)

CapsoVision recorded quarterly Payables of $1.1 million in Q4 2025, down 15.02% quarter-over-quarter from $1.3 million in Q3 2025, and up 52.6% year-over-year from $749000.0 in Q4 2024.

CapsoVision's Payables history runs 2 years deep, the most recent figure standing at $1.1 million for Q4 2025.

  • In Q4 2025, Payables rose 52.6% year-over-year to $1.1 million; the TTM figure through Dec 2025 stood at $1.1 million (up 52.6% YoY), while the FY2025 annual figure was $1.1 million, up 52.6% from the prior year.
  • Payables came in at $1.1 million for Q4 2025 at CapsoVision, down from $1.3 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $2.2 million in Q2 2025 to a low of $749000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 5.78 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.93 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 2.57 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.14 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 181.10 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.74 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.07 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 3.42 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 457.70 Mn
10 CapsoVision 167.59 Mn 157.48 Mn 1.95 Mn 1.14 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.14 Mn
Sep 30, 2025 1.35 Mn
Jun 30, 2025 2.16 Mn
Dec 31, 2024 749,000.00